| Literature DB >> 14619456 |
Hugh D Riordan1, Ronald B Hunninghake, Neil H Riordan, James J Jackson, Xiaolong Meng, Paul Taylor, Joseph J Casciari, Michael J González, Jorge R Miranda-Massari, Edna M Mora, Norberto Rosario, Alfredo Rivera.
Abstract
High dose intravenous(i.v.) ascorbic acid (AA) has been used as therapy for infectious disease from bacterial and viral origin and adjuvant therapy for cancer. In this publication we describe a clinical protocol that has been developed over the past twenty years utilizing high dose i.v. AA as therapy for cancer. This includes principles of treatment, rationale, baseline workup, infusion protocol, precautions and side effects.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14619456
Source DB: PubMed Journal: P R Health Sci J ISSN： 0738-0658 Impact factor: 0.705